Moderna, Inc. (NASDAQ: MRNA) Q1 2021 earnings call dated May. 06, 2021
Corporate Participants:
Lavina Talukdar — Senior Vice President and Head of Investor Relations
Stephane Bancel — Chief Executive Officer
Corinne Le Goff — Chief Commercial Officer
David Meline — Chief Financial Officer
Stephen Hoge — President
Analysts:
Salveen Richter — Goldman Sachs — Analyst
Matthew Harrison — Morgan Stanley — Analyst
Edward Tenthoff — Piper Sandler — Analyst
Michael Yee — Jefferies — Analyst
Gena Wang — Barclays — Analyst
Geoffrey Meacham — Bank of America — Analyst
Cory Kasimov — J.P. Morgan — Analyst
Hartaj Singh — Oppenheimer & Co. — Analyst
Joseph Stringer — Needham & Company — Analyst
Mani Foroohar — SVB Leerink — Analyst
Simon Baker — Redburn — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to
Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights
Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per
BA Earnings: Highlights of Boeing’s Q1 2024 financial results
The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,
Listen On
